Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and PK of Rocuronium Maintenance Doses Under Sevoflurane or Propofol
NCT00984633Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2003
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rocuronium, sponsored by Merck & Co.. Started Jun 2003; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT00984633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984633.